FILTER

Refine your search with the following facets to narrow down your results.

3 Current news of g-st-antivirals

image description

Antiviral nasal spray for common colds or more severe respiratory diseases

Start-up G.ST Antivirals reports start of Phase II trial and announces appointment of Ronald Bruce Turner as new Chief Medical Officer

16-Apr-2024 - G.ST Antivirals, aspin-off from the Medical University of Vienna applying innovative, host cell-based strategies to develop broad-spectrum antivirals against respiratory tract infections, announced the appointment of Ronald Bruce Turner, MD, as new Chief Medical Officer (CMO). An expert in the ...

antiviral drugs antivirals nasal sprays +3
image description

New therapeutic approach against rhinovirus infections

Biotech-Start-up G.ST Antivirals starts first clinical trial

16-May-2022 - Less than three years after its foundation, the start-up G.ST Antivirals reaches a major milestone in the development of its lead asset and begins clinical phase I at the Vienna General Hospital. G.ST Antivirals is testing a nasal spray, which was developed specifically for use against colds and ...

Covid-19 nasal sprays respiratory diseases +2
image description

Sugar as a remedy for the common cold

Start-up developing therapies to combat viral infections

11-Mar-2020 - Viral infections are currently more topical than ever. Not only are coronavirus and influenza constantly in the news but it is also the season for colds – and, as we all know, colds are caused by rhinovirus. A Medical University of Vienna start-up, "G.ST Antivirals GmbH" now has viral infections ...

rhinoviruses viral infection